The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Towards a molecular algorithm predicting glioma treatment response and resistance: A biomarker analysis and path to real time profiling in N2M2.
 
Tobias Kessler
No Relationships to Disclose
 
Felix Sahm
Honoraria - Medac
Travel, Accommodations, Expenses - Agilent; Illumina; Roche
 
Gnana Prakash Balasubramanian
No Relationships to Disclose
 
Elke Pfaff
No Relationships to Disclose
 
David T. W. Jones
Patents, Royalties, Other Intellectual Property - Pat. pending; “DNA methylation-based method for classifying tumor species”
 
Antje Wick
No Relationships to Disclose
 
Juergen Debus
Consulting or Advisory Role - Merck (Inst)
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - Merck
 
Andreas Unterberg
Research Funding - Edge Pharma (Inst); Vasopharm (Inst)
 
Anne Berberich
No Relationships to Disclose
 
Christel Herold-Mende
Patents, Royalties, Other Intellectual Property - Apogenix; Bayer; CLS
 
Stefan M. Pfister
No Relationships to Disclose
 
Benedikt Brors
No Relationships to Disclose
 
Susan Dettmer
No Relationships to Disclose
 
Irini Karapanagiotou-Schenkel
No Relationships to Disclose
 
Frank Winkler
Honoraria - EMD Serono
Consulting or Advisory Role - Roche
Research Funding - Genentech; Roche
 
Martin Bendszus
No Relationships to Disclose
 
Andreas von Deimling
Research Funding - Bayer
Patents, Royalties, Other Intellectual Property - Patent for BRAFV600E antibody VE1 administered by the German Cancer Center (DKFZ); Patent for IDH1R132H antibody H09 administered by the German Cancer Center (DKFZ)
Travel, Accommodations, Expenses - Roche
 
Michael Platten
Honoraria - Merck; Novartis; Roche
Consulting or Advisory Role - Bayer (Inst); Novartis (Inst); Novartis (Inst); Roche (Inst)
Research Funding - Bayer (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Diagnosing and treating IDH1-mutant cancers; Treating cancers with AHR antagonists; Treating H3.3K27M-mutant cancers
Travel, Accommodations, Expenses - Merck; Novartis; Roche
 
Wolfgang Wick
Honoraria - MSD Oncology
Consulting or Advisory Role - Celldex; Roche/Genentech
Research Funding - Apogenix (Inst); Boehringer Ingelheim (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)